Back to Journals » International Journal of General Medicine » Volume 16

KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy

Total article views   HTML views PDF downloads Totals
1,946 Dovepress* 1,857+ 45 1,902
PubMed Central* 89 50 139
Totals 1,946 95 2,041
*Since 21 August 2023

View citations on PubMed Central and Google Scholar